Related Experiment Video

Updated: Aug 4, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary

Vijay Nambi1, John M Buergler, Nasser M Lakkis

  • 1Section of Cardiology, Baylor College of Medicine, Methodist DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, Texas. USA.

The American Journal of Cardiology
|August 16, 2005
PubMed

Insights

Percutaneous coronary intervention combined with alcohol septal ablation effectively treated obstructive hypertrophic cardiomyopathy and coronary artery disease. This approach significantly reduced left ventricular outflow tract obstruction one year post-procedure without restenosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Surgery

Background:

  • Obstructive hypertrophic cardiomyopathy (oHCM) presents a significant clinical challenge.
  • Dynamic left ventricular outflow tract obstruction (LVOTO) is a hallmark of oHCM.
  • Coexisting coronary artery disease (CAD) complicates management strategies.

Purpose of the Study:

  • To evaluate the efficacy of combined percutaneous coronary intervention (PCI) and alcohol septal ablation (ASA) in patients with oHCM and single-vessel CAD.
  • To assess the impact of this combined therapy on dynamic LVOTO and coronary restenosis.

Main Methods:

  • Seven patients with oHCM and single-vessel CAD were included.
  • Patients underwent PCI for their coronary lesions.
  • Alcohol septal ablation was performed for dynamic LVOTO.

Main Results:

  • A significant reduction in dynamic LVOTO was observed one year after the combined procedure.
  • No clinical evidence of coronary restenosis was noted at the one-year follow-up.
  • The combined therapeutic approach demonstrated favorable short-term outcomes.

Conclusions:

  • Combined PCI and ASA is a viable treatment option for select patients with oHCM and concomitant CAD.
  • This strategy effectively alleviates LVOTO while addressing significant coronary stenoses.
  • Further research with larger cohorts is warranted to confirm long-term efficacy and safety.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs07:24

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs

Published on: March 13, 2026

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...